ECwN + varenicline

ECwN + varenicline appears to be a combination treatment used for smoking cessation. It includes varenicline (previously marketed as Chantix) and likely a nicotine replacement therapy (NRT) component represented by "ECwN". Varenicline is a prescription medication that aids smoking cessation by acting as a partial agonist at nicotinic acetylcholine receptors (nAChRs) in the brain. It stimulates these receptors at a lower level than nicotine, thereby reducing cravings and withdrawal symptoms, while also blocking nicotine from binding. Clinical trials mentioned in the search results suggest that combining varenicline with nicotine patches can improve efficacy for smoking cessation compared to varenicline alone, particularly in specific groups like male smokers, highly dependent smokers, and heavy drinkers. The combination appears generally well-tolerated according to trial data, although it may result in more side effects than varenicline used alone. Potential side effects reported include nausea, vomiting, headache, dizziness, upset stomach, and tiredness.